Combining methionine-PET and MRI fluid-attenuated inversion-recovery mismatch to determine glioma molecular subtype.

MLA

Ohmura, Kazufumi, et al. “Combining Methionine-PET and MRI Fluid-Attenuated Inversion-Recovery Mismatch to Determine Glioma Molecular Subtype.” Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging, vol. 33, no. 4, July 2023, pp. 652–60. EBSCOhost, https://doi.org/10.1111/jon.13114.

APA

Ohmura, K., Kumagai, N., Kumagai, M., Ikegame, Y., Shinoda, J., Yano, H., Muragaki, Y., & Iwama, T. (2023). Combining methionine-PET and MRI fluid-attenuated inversion-recovery mismatch to determine glioma molecular subtype. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging, 33(4), 652–660. https://doi.org/10.1111/jon.13114

Chicago

Ohmura, Kazufumi, Nobutoshi Kumagai, Morio Kumagai, Yuka Ikegame, Jun Shinoda, Hirohito Yano, Yoshihiro Muragaki, and Toru Iwama. 2023. “Combining Methionine-PET and MRI Fluid-Attenuated Inversion-Recovery Mismatch to Determine Glioma Molecular Subtype.” Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging 33 (4): 652–60. doi:10.1111/jon.13114.